Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Carcinoma, Renal Cell (Phase 1)
Cholangiocarcinoma (Phase 2)
Colorectal Neoplasms (Phase 2)
Fallopian Tube Neoplasms (Phase 1)
Hamartoma (Phase 1)
Hodgkin Disease (Phase 2)
Infections (Phase 1/Phase 2)
Kidney Neoplasms (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Prolymphocytic (Phase 1/Phase 2)
Leukemia, Prolymphocytic, T-Cell (Phase 2)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 1)
Lymphoma, B-Cell, Marginal Zone (Phase 1)
Lymphoma, Follicular (Phase 1)
Lymphoma, Mantle-Cell (Phase 1)
Lymphoma, Non-Hodgkin (Phase 2)
Melanoma (Phase 2)
Melanoma, Experimental (Phase 2)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 1)
Neoplasms (Phase 2)
Neuroblastoma (Phase 1)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 1)
Sarcoma (Phase 1)
Uterine Cervical Neoplasms (Phase 2)
Waldenstrom Macroglobulinemia (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
